Lactylation-driven FTO-mediated m6A modification of CDK2 aggravates diabetic microvascular anomalies https://www.biorxiv.org/content/10.1101/2023.05.19.541470v1?med=mas
Lactylation-driven FTO-mediated m6A modification of CDK2 aggravates diabetic microvascular anomalies https://www.biorxiv.org/content/10.1101/2023.05.19.541470v1?med=mas